Overview

Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

Status:
Completed
Trial end date:
2019-07-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of a combination of chemotherapy and radiotherapy in breast cancer patients after breast surgery.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Treatments:
Carboplatin